None

Omicia Names New CEO, Prepares Genome Interpretation Platform Launch

Fort Mills Times | Omicia (a 2012 Bio-IT World Best Practices awards winner) has appointed Mike Aicher as CEO.

Omicia appoints Mike Aicher as new CEO

Genome Interpretation Company Omicia has named Mike Aicher as the new chief executive officer (CEO).

Real Time Genomics and Omicia Partner on a Platform for Integrated Genomic Analysis for Childhood Disease

SAN FRANCISCO, California (PRWEB) April 16, 2013 Real Time Genomics, Inc., and Omicia, Inc. today announced a commercial partnership to deliver genome analytics for the clinical interpretation of g...

Genome Interpretation Company Omicia Appoints Mike Aicher as CEO

Omicia, Inc., a privately held company offering integrated solutions for interpreting human genome sequences, today announced the appointment of Mike Aicher as Chief Executive Off...

Spiral Genetics Closes $3 Million in Funding Led by DFJ and Announces Partnership with Omicia

SEATTLE, March 12, 2013 /PRNewswire/ -- Spiral Genetics, a cloud-based big data bioinformatics company, announced today that it closed its Series A financing, led by venture capital firm DFJ.
...

Ariosa Diagnostics Welcomes New Board Member Michael A. Aicher

SAN JOSE, Calif., Feb. 25, 2013 /PRNewswire/ -- Ariosa Diagnostics, maker of the non-invasive Harmony™ Prenatal Test for detection of common genetic conditions, has announced the ele...

Dr. Paul Billings joins Trovagene's Scientific Advisory Board

SAN DIEGO, Nov. 19, 2012 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of transrenal molecular diagnostics, announced today that Dr. Paul Billings has joined the Company's Scie...

Thirty teams compete to interpret three families' genomes

International contestants vie to bring "CLARITY" to DNA sequencing information BOSTON, Aug. 15, 2012 /PRNewswire-USNewswire/ -- DNA sequencing is rapidly getting faster and cheaper, but...

None